Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Deleted the notice about a lapse in government funding, and the page now reflects the new revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA government funding status notice was added and the page revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedMinor UI and metadata updates: the page now shows a glossary, updates the QC-related label to 'Last Update Submitted that Met QC Criteria', and adds 'No FEAR Act Data' and a new 'Revision: v3.4.0' indicator, while the older 'Last Update Submitted that met QC Criteria' label and earlier 'No FEAR Act data' wording were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4. This is a minor administrative update with no substantive changes to the study information.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page reorganizes site data into a single 'Locations' section listing participating states, replacing the prior per-state subsections, and updates the revision to v3.3.3.SummaryDifference0.8%

- Check92 days agoChange DetectedThe Publications section description was updated to indicate PubMed as the data source and that publications may not all pertain to the study; the revision note shows an update from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.